Melissa Barber is a Postdoctoral Fellow at Yale Law School and Yale School of Medicine (joint appointment) and an affiliate of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT). She received a PhD in Population Health Science from Harvard University in 2023. Her research crosses economics, political science, and law to better understand pharmaceutical markets and their relationship to public health.
Melissa received her A.B. degree in Social Studies from Harvard University and MPhil in Development Studies from the University of Cambridge.
She has worked on pharmaceutical issues for the World Health Organization (WHO), Médecins Sans Frontières (MSF), the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM), the World Bank, the Clinton Health Access Initiative (CHAI), and the Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) study.
Featured work
Pharmaceutical regulation in the UK
A case study